ClinicalTrials.Veeva
Menu

Find clinical trials for Prostate Cancer in New York, NY

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Prostatic Cancer
Cancer
Breast Cancer
Ovarian Cancer
Endometrial Cancer
Neoplasm Metastasis
Non-Small-Cell Lung Carcinoma

Prostate Cancer trials near New York, NY, USA:

MR/TRUS Fusion Guided Prostate Biopsy - An Improved Way to Detect and Quantify Prostate Cancer

biopsy alone in diagnosing subjects with clinically significant prostate cancer with MRI visible lesions. This study will consist o...

Enrolling
Elevated Prostate Specific Antigen
Prostate Disease
Device: MR/TRUS Fusion Guided Prostate Biopsy
Other: MR US Fusion Guided Prostate Biopsy
Ardeshir Rastinehad

New York, New York, United States and 2 other locations

and docetaxel in patients with newly metastatic, hormone-sensitive prostate cancer (mHSPC), using a primary endpoint of undetectabl...

Active, not recruiting
Prostate Cancer Metastatic
Drug: Leuprolide Acetate
Drug: Degarelix

Phase 2

Mark Stein

New York, New York, United States

study is a randomized study that compares 5 radiation therapy treatments to 2 radiation therapy treatments in men with low or intermediate-risk prostate...

Active, not recruiting
Prostate Cancer
Radiation: Radiation Therapy

Phase 2

Weill Cornell Medicine (WCM)
Weill Cornell Medicine (WCM)

New York, New York, United States and 1 other location

of this study is to evaluate the safety, tolerability, and antitumour activity of AZD0754 CAR T-cell therapy in participants with metastatic prostate...

Enrolling
Metastatic Prostate Cancer
Biological: AZD2287
Biological: AZD0754

Phase 1, Phase 2

AstraZeneca
AstraZeneca

New York, New York, United States and 14 other locations

This is a phase 1 study to assess the safety and tolerability of ARX517 as monotherapy or combination therapy in adult subjects with metastatic prostate...

Enrolling
Metastatic Prostate Cancer
Drug: Apalutamide
Drug: Abiraterone acetate

Phase 1

Janssen (J&J Innovative Medicine)
Janssen (J&J Innovative Medicine)

New York, New York, United States and 11 other locations

in men with biopsy-proven, low-risk or favorable intermediate-risk prostate cancer managed with active surveillance. The study aims...

Enrolling
Prostate Adenocarcinoma
Prostatic Neoplasms
Drug: Flotufolastat F18
Radiation: rhPSMA-7.3 (18F) PET/CT Imaging (Flotufolastat F18, POSLUMA®)

Phase 2

Mount Sinai Health System
Mount Sinai Health System

New York, New York, United States

and with darolutamide in men with metastatic castration-resistant prostate cancer. The study aims to assess whether the drug is saf ...

Enrolling
mCRPC (Metastatic Castration-resistant Prostate Cancer)
Metastatic Castration-resistant Prostate Cancer, mCRPC
Drug: KTX-2001
Drug: KTX-2001 + Darolutamide (NUBEQA®)

Phase 1

K36 Therapeutics

New York, New York, United States and 12 other locations

the UroNav software and DynaCAD software for planning and treating prostate cancer as an add on to the already approved workflow of...

Enrolling
Prostate Disease
Prostate Cancer
Device: Cryo-ablation Using DynaCAD / UroNAV preplanning / guidance
Northwell Health
Northwell Health

New York, New York, United States and 2 other locations

purpose of this study is to assess the safety, tolerability, and preliminary efficacy of BMS-986460 in men with Metastatic Castration-resistant Prostate...

Active, not recruiting
Metastatic Castration-resistant Prostate Cancer
Drug: BMS-986460

Phase 1

Bristol-Myers Squibb (BMS)
Bristol-Myers Squibb (BMS)

New York, New York, United States and 6 other locations

The main purpose of this study is to assess the safety and tolerability of AZD0516 as monotherapy and/or in combination with other anti-cancer...

Enrolling
Metastatic Prostate Cancer
Drug: AZD9574
Drug: AZD0516

Phase 1, Phase 2

AstraZeneca
AstraZeneca

New York, New York, United States and 50 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems